Home Markets EU Medtech: What is the risk from the Section 232 investigation? EU Medtech: What is the risk from the Section 232 investigation? Andrew M Oct 04, 2025 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/eu-medtech-what-is-the-risk-from-the-section-232-investigation-4260987 European Union Market Updates Medtech www.investing.com/news/stock-market-news/eu-medtech-what-is-the-risk-from-the-section-232-investigation-4260987